International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Neostigmine Methylsulfate 0.5-mg/mL Injection

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2013 - Volume 17, Number 1
View All Articles in Issue

Page(s): 70

Neostigmine Methylsulfate 0.5-mg/mL Injection Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Neostigmine Methylsulfate 0.5-mg/mL Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, neostigmine methylsulfate, formulation, myasthenia gravis, anesthesia, neuromuscular blockade reversal, cholinesterase inhibitor, acetylcholine agonist

Related Categories: FORMULATIONS, PARENTERALS, STERILE PREPARATIONS, MUSCULOSKELETAL DISORDERS, NEUROLOGY, SURGERY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Neostigmine Methylsulfate 0.5-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 70
Stability of Neostigmine Methylsulfate Injection at Ambient Temperature and 4°C in Polypropylene Syringes Storms Meredith L, Stewart James T, Warren Flynn W	Nov/Dec 2002 Pg. 475-477
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Neostigmine Bromide 15-mg Capsules Allen Loyd V Jr	Jan/Feb 2014 Pg. 64
Veterinary Compounding for Myasthenia Gravis Davidson Gigi S	Sep/Oct 2008 Pg. 398-401
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A	Jul/Aug 2008 Pg. 368-371
Basics of Compounding for Disorders of the External Ear Allen Loyd V Jr	Jan/Feb 2004 Pg. 46-48
Succinylcholine Chloride 50-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2013 Pg. 335
Ephedrine Sulfate 50-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2014 Pg. 411
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion Allen Loyd V Jr	Nov/Dec 2011 Pg. 504
Vercuronium Bromide 1-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2012 Pg. 509
Rocuronium Bromide 10-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2014 Pg. 147
Bupivacaine Hydrochloride 0.5% Injection Allen Loyd V Jr	May/Jun 2014 Pg. 234
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray Allen Loyd V Jr	Mar/Apr 2016 Pg. 147
Glycopyrrolate 0.2 mg/mL in Ora-Plus:Ora-Sweet (1:1) Allen Loyd V Jr	Mar/Apr 2020 Pg. 132
Imatinib 40-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 510
Physostigmine Salicylate 1-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2015 Pg. 150
Physostigmine Salicylate 1-mg/mL Injection Allen Loyd V Jr	May/Jun 2015 Pg. 246
Return to Top